Leucine metabolism pathway

The **leucine metabolism pathway** is a series of biochemical reactions responsible for the breakdown and utilization of the essential branched-chain amino acid leucine. This metabolic route occurs primarily in skeletal muscle, liver, and adipose tissue. The process begins with the transport of leucine into cells via specific transporters such as LAT1. Once inside, leucine undergoes transamination by branched-chain amino acid aminotransferase (BCAT) to form α-ketoisocaproate (α-KIC). α-KIC is then further metabolized by the branched-chain α-ketoacid dehydrogenase complex (BCKDC) to produce acetyl-CoA and succinyl-CoA, which enter the citric acid cycle for energy production[1][3][6]. Leucine's metabolites also serve as precursors for cholesterol synthesis and fatty acid biosynthesis. Additionally, leucine acts as a signaling molecule that activates mTORC1—a key regulator of protein synthesis—thereby promoting muscle growth and inhibiting protein degradation[2][5][6]. Disruptions in this pathway are implicated in metabolic diseases such as maple syrup urine disease; excessive intake can lead to toxicity including hyperammonemia or neurological compromise[4]. **Note:** The "leucine metabolism pathway" itself is not a single molecular target but rather a collection of enzymes, transporters, intermediates, and regulatory proteins involved in processing leucine within cells. Therefore, it does not fit standard definitions for therapeutic targets like receptors or enzymes; instead it describes an entire metabolic process involving multiple molecular entities. If you require information on specific enzymes or proteins within this pathway—such as BCAT or BCKDC—please specify so structured data can be provided at that level.

Other names

Branched-chain amino acid metabolism (BCAA metabolism)Leucine catabolic pathwayLeucine degradation pathway